PFIZER INC. (LON:PFZ) Files An 8-K Other EventsItem 8.01 Other Events
On December7, 2017, Pfizer Inc. (the “Company”) issued a press release announcing the commencement of (i)a private offer to exchange any and all of its outstanding £1,500,000,000 6.500per cent. Notes due 2038 (the “2038 Notes”) for newly issued debt securities of the Company, which exchange offer is being made exclusively to the Offering Memorandum dated December7, 2017 and related Notice of Guaranteed Delivery, (ii)an offer to purchase for cash any and all of its outstanding 2038 Notes from holders thereof, which offer to purchase is being made exclusively to the Offer to Purchase dated December7, 2017 and related Notice of Guaranteed Delivery, (iii)an offer to purchase for cash (the “2021 Notes Tender Offer”) any and all of its outstanding €2,000,000,000 5.750per cent. Notes due 2021 (the “2021 Notes”) from holders thereof and (iv)a solicitation of consents from the holders of the 2021 Notes to certain amendments to the 2021 Notes and to the indenture dated as January30, 2001, as amended and supplemented by the second supplemental indenture dated as of June2, 2009, to which the 2021 Notes were issued (the “Consent Solicitation” and, together with the 2021 Notes Tender Offer, the “2021 Notes Offer”). The 2021 Notes Offer is being made exclusively to the Offer to Purchase and Consent Solicitation Statement dated December7, 2017.
A copy of the Company’s press release announcing the foregoing transactions is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 8.01 Financial Statements and Exhibits
|99.1||Press Release of Pfizer Inc., dated December 7, 2017|
PFIZER INC ExhibitEX-99.1 2 d481310dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 For immediate release Media Contact December 7,…To view the full exhibit click